Companies Medifast Inc
Medifast (MED): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Medifast Inc’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $7,039,062FY2023
- $5,609,855FY2024
- $5,584,551FY2025
CEO total pay was $5,584,551 in fiscal 2025, down from $5,609,855 in fiscal 2024.
FY2025: salary $1,000,000 · stock awards $4,567,664 · option awards $0
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Daniel Chard | $1,000,000 | — | $4,567,664 | $0 | $0 | $0 | $16,886 | $5,584,551 |
| Chairman & Chief Executive Officer | ||||||||
| Anthony Tyree | 415,873 | — | 162,194 | 0 | 145,556 | 0 | 761,097 | 1,484,720 |
| Former Chief Business Operations Officer | ||||||||
| James Maloney | 527,085 | — | 700,427 | 0 | 184,480 | 0 | 16,403 | 1,428,396 |
| Chief Financial Officer | ||||||||
| Nicholas Johnson | 440,352 | — | 585,163 | 0 | 154,123 | 0 | 15,980 | 1,195,619 |
| Chief Field Operations Officer | ||||||||
| Jason Groves | 427,781 | — | 568,465 | 0 | 149,723 | 0 | 14,483 | 1,160,452 |
| Chief Legal Officer & Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Daniel Chard | $5,584,551 | $5,609,855 | $7,039,062 | ↓ −25,304 |
| Anthony Tyree | 1,484,720 | 1,065,622 | 1,608,190 | ↑ +419,098 |
| James Maloney | 1,428,396 | 1,347,485 | 2,009,824 | ↑ +80,911 |
| Nicholas Johnson | 1,195,619 | 1,128,323 | 1,703,445 | ↑ +67,296 |
| Jason Groves | 1,160,452 | 1,094,793 | 1,632,143 | ↑ +65,659 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | — |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| James Maloney | PSU | 2025-03-25 | 6,040 | 24,161 | — | 44,294 | $365,556 |
| Jason Groves | PSU | 2025-03-25 | 4,902 | 19,609 | — | 35,949 | 296,684 |
| Daniel Chard | PSU | 2025-03-25 | 46,858 | 187,430 | — | 343,615 | 2,835,816 |
| Nicholas Johnson | PSU | 2025-03-25 | 5,046 | 20,185 | — | 37,005 | 305,399 |
| Anthony Tyree | PSU | 2025-03-25 | 1,589 | 6,354 | — | 11,649 | 96,141 |
| Jason Groves | PSU | 2025-03-25 | — | — | 19,609 | — | 271,781 |
| Daniel Chard | PSU | 2025-03-25 | — | — | 124,953 | — | 1,731,849 |
| James Maloney | PSU | 2025-03-25 | — | — | 24,161 | — | 334,871 |
| Nicholas Johnson | PSU | 2025-03-25 | — | — | 20,185 | — | 279,764 |
| Anthony Tyree | PSU | 2025-03-25 | — | — | 4,766 | — | 66,053 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| James Maloney | $0 | $700,427 | $0 | 100.0% |
| Jason Groves | 0 | 568,465 | 0 | 100.0% |
| Daniel Chard | 0 | 4,567,665 | 0 | 100.0% |
| Nicholas Johnson | 0 | 585,163 | 0 | 100.0% |
| Anthony Tyree | 0 | 162,194 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jason Groves | RSU | 1,238 | — | $13,222 |
| Nicholas Johnson | RSU | 1,308 | — | 13,969 |
| James Maloney | RSU | 1,525 | — | 16,287 |
| Jason Groves | RSU | 4,718 | — | 50,388 |
| Nicholas Johnson | RSU | 4,856 | — | 51,862 |
| Daniel Chard | RSU | 5,603 | — | 59,840 |
| James Maloney | RSU | 5,812 | — | 62,072 |
| Jason Groves | PSU | 7,076 | — | 75,572 |
| Nicholas Johnson | PSU | 7,284 | — | 77,793 |
| James Maloney | PSU | 8,718 | — | 93,108 |
| Jason Groves | PSU | 19,609 | — | 209,424 |
| Jason Groves | RSU | 19,609 | — | 209,424 |
| Nicholas Johnson | PSU | 20,185 | — | 215,576 |
| Nicholas Johnson | RSU | 20,185 | — | 215,576 |
| James Maloney | PSU | 24,161 | — | 258,039 |
| James Maloney | RSU | 24,161 | — | 258,039 |
| Daniel Chard | RSU | 30,058 | — | 321,019 |
| Daniel Chard | PSU | 67,631 | — | 722,299 |
| Daniel Chard | RSU | 124,953 | — | 1,334,498 |
| Daniel Chard | PSU | 187,430 | — | 2,001,752 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Jeffrey J. BrownIndependent · Audit (Chair) · Executive · Not standing for re-election | $10,000 | $270,495 | $0 | $0 | $0 | $280,495 |
| Scott SchlackmanIndependent · Audit · Compensation (Chair) | 110,000 | 146,524 | 0 | 0 | 0 | 256,524 |
| Andrea B. ThomasIndependent · Compensation · Nominating/Corporate Governance (Chair) | 97,500 | 146,524 | 0 | 0 | 0 | 244,024 |
| Michael A. HoerIndependent · Audit · Compensation · Not standing for re-election | 82,500 | 146,524 | 0 | 0 | 0 | 229,024 |
| Ming XianIndependent · Nominating/Corporate Governance | 0 | 225,415 | 0 | 0 | 0 | 225,415 |
| Elizabeth A. GearyIndependent · Nominating/Corporate Governance | 70,000 | 146,524 | 0 | 0 | 0 | 216,524 |
| Daniel R. ChardEmployee director · Board Chair · Executive (Chair) | — | — | — | — | — | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | — |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | Non-Employee Directors: 5x amount of annual cash retainer |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $370,000 |
| Equity awards (grant-date value) | $1,082,006 |
| All other compensation | $0 |
| Total cost of the board | $1,452,006 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Medifast as a peer
Companies that benchmark against MED
10 companies name MED as a compensation peer
- BELLRING BRANDS, INC.BRBRFY2025
- BEYOND MEAT, INC.BYNDFY2025
- Esquire Financial Holdings, Inc.ESQFY2025
- Freshpet, Inc.FRPTFY2025
- HERBALIFE LTD.HLFFY2025
- Lifevantage CorpLFVNFY2026
- NATURES SUNSHINE PRODUCTS INCNATRFY2025
- OLAPLEX HOLDINGS, INC.OLPXFY2025
- PETMED EXPRESS INCPETSFY2026
- SENSIENT TECHNOLOGIES CORPSXTFY2025
- Spectrum Brands Holdings, Inc.SPBFY2025
- USANA HEALTH SCIENCES INCUSNAFY2025
Each company listed discloses MED in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named MED in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Peer reciprocity
Of the companies Medifast Inc names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Medifast Inc.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewell Personal Care Company | 2025 | Rod Little | $1,100,000 | $7,576,100 | — | $907,500 | $9,754,366 |
| 2 | Herbalife Ltd. | 2025 | Stephan Gratziani | 930,385 | 2,799,996 | 1,399,998 | 1,411,650 | 7,384,841 |
| 3 | Olaplex Holdings, Inc. | 2025 | Amanda Baldwin | 1,000,000 | 5,000,000 | 0 | 515,000 | 6,541,537 |
| 4 | Medifast Inc | 2025 | Daniel Chard | 1,000,000 | 4,567,664 | 0 | 0 | 5,584,551 |
| 5 | B&G Foods, Inc. | 2025 | Kenneth Keller | 1,224,258 | 2,625,864 | 0 | 710,437 | 4,589,619 |
| 6 | Flowers.com, Inc. | 2026 | Adolfo Villagomez | 1,000,000 | 500,000 | 0 | 169,000 | 1,710,502 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Medifast Inc | not disclosed | not disclosed | not disclosed | not disclosed |
| B&G Foods, Inc. | not disclosed | not disclosed | not disclosed | Meridian Compensation Partners |
| Edgewell Personal Care Company | 66% | not disclosed | No | Meridian |
| Flowers.com, Inc. | not disclosed | RSU 50 · PRSU 50 | not disclosed | Pearl Meyer |
| Herbalife Ltd. | not disclosed | PSU 50 · SAR 25 · RCU 25 | not disclosed | Meridian Compensation Partners, LLC |
| Olaplex Holdings, Inc. | 103% | RSU 100 | not disclosed | Aon |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-19 | 3,996,046 | 637,173 | 15,874 | 86.25% | Passed |
| 2025 | 2025-06-18 | 3,585,469 | 2,477,849 | 128,492 | 59.13% | Passed |
| 2024 | 2024-06-19 | 6,875,928 | 248,088 | 20,611 | 96.52% | Passed |
| 2023 | 2023-06-14 | 7,495,497 | 372,673 | 87,201 | 95.26% | Passed |
| 2022 | 2022-06-15 | 8,615,230 | 304,225 | 153,696 | 96.59% | Passed |
| 2021 | 2021-06-02 | 8,651,595 | 244,600 | 20,001 | 97.25% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-19 | 86.25%a |
| 2025 | 2025-06-18 | 59.13%b |
| 2024 | 2024-06-19 | 96.52%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 57 : 1 |
|---|---|
| CEO total compensation | — |
| Median employee compensation | $97,437 |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (38 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Daniel Chard. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · page 35. As printed: 5,584,551. View filing ↗
- Section 01, Anthony Tyree. DEF 14A, filed 2026-04-06. Section “Executive Compensation”. As printed: 1,484,720. View filing ↗
- Section 01, James Maloney. DEF 14A, filed 2026-04-06. Section “Executive Compensation”. As printed: 1,428,396. View filing ↗
- Section 01, Nicholas Johnson. DEF 14A, filed 2026-04-06. Section “Executive Compensation”. As printed: 1,195,619. View filing ↗
- Section 01, Jason Groves. DEF 14A, filed 2026-04-06. Section “Executive Compensation”. As printed: 1,160,452. View filing ↗
- Section 03, James Maloney PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Jason Groves PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Daniel Chard PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Nicholas Johnson PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Anthony Tyree PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Jason Groves PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Daniel Chard PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, James Maloney PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Nicholas Johnson PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Anthony Tyree PSU. DEF 14A, filed 2026-04-06. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-06. Section “CEO Pay Ratio”. As printed: 57 : 1. View filing ↗
- Section 08, Jeffrey J. Brown. DEF 14A, filed 2026-04-06. Section “Director Compensation”. As printed: 280,495. View filing ↗
- Section 08, Scott Schlackman. DEF 14A, filed 2026-04-06. Section “Director Compensation”. As printed: 256,524. View filing ↗
- Section 08, Andrea B. Thomas. DEF 14A, filed 2026-04-06. Section “Director Compensation”. As printed: 244,024. View filing ↗
- Section 08, Michael A. Hoer. DEF 14A, filed 2026-04-06. Section “Director Compensation”. As printed: 229,024. View filing ↗
- Section 08, Ming Xian. DEF 14A, filed 2026-04-06. Section “Director Compensation”. As printed: 225,415. View filing ↗
- Section 08, Elizabeth A. Geary. DEF 14A, filed 2026-04-06. Section “Director Compensation”. As printed: 216,524. View filing ↗
- Section 08, Daniel R. Chard. DEF 14A, filed 2026-04-06. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-26. Item 5.07 · say-on-pay result. As reported: 86.25% (votes for as printed: 3,996,046). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-20. Item 5.07 · say-on-pay result. As reported: 59.13% (votes for as printed: 3,585,469). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-21. Item 5.07 · say-on-pay result. As reported: 96.52% (votes for as printed: 6,875,928). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 370,000 + equity 1,082,006 + all other 0 = 1,452,006, summed across the director compensation table rows.
- Edgewell Personal Care Company, Section 10b CEO total. DEF 14A, filed 2025-12-22. CEO total compensation as printed in Edgewell Personal Care Company's own proxy. As printed: 9,754,366. View filing ↗
- Herbalife Ltd., Section 10b CEO total. DEF 14A, filed 2026-03-17. CEO total compensation as printed in Herbalife Ltd.'s own proxy. As printed: 7,384,841. View filing ↗
- Olaplex Holdings, Inc., Section 10b CEO total. DEF 14A, filed 2026-05-29. CEO total compensation as printed in Olaplex Holdings, Inc.'s own proxy. As printed: 6,541,537. View filing ↗
- Medifast Inc (subject), Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Medifast Inc's own proxy. As printed: 5,584,551. View filing ↗
- B&G Foods, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in B&G Foods, Inc.'s own proxy. As printed: 4,589,619. View filing ↗
- Flowers.com, Inc., Section 10b CEO total. DEF 14A, filed 2026-10-23. CEO total compensation as printed in Flowers.com, Inc.'s own proxy. As printed: 1,710,502. View filing ↗
- Section 10a, Edgewell Personal Care Company reciprocity. DEF 14A. Edgewell Personal Care Company's most recent proxy was read; its disclosed peer group does not include Medifast Inc. View filing ↗
- Section 10a, B&G Foods, Inc. reciprocity. DEF 14A. B&G Foods, Inc.'s most recent proxy was read; its disclosed peer group does not include Medifast Inc. View filing ↗
- Section 10a, Herbalife Ltd. reciprocity. DEF 14A. Herbalife Ltd. names Medifast Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗